Literature DB >> 4025020

Creatine kinaseBB-activity after head trauma related to outcome.

L Rabow, G Hedman.   

Abstract

The brain-type isoenzyme of creatine kinase was determined in serum (S) and cerebrospinal fluid (CSF) in 37 patients with severe head injury, and a correlation was made with the Glasgow coma score and Glasgow outcome score. All patients with normal S-CKBB and CSF-CKBB activities had a coma score of 15, i.e., no neurological deficits, at six hours after the trauma and a good outcome. All 15 patients with a significant increase in the enzyme in serum and CSF had a coma score less than 15. The outcome was still good for five of these patients, while six were moderately disabled, two were severely disabled, and two died. There was no correlation between the individual CKBB-values and the outcome.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4025020     DOI: 10.1007/bf01418476

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  17 in total

1.  Lactic dehydrogenase isoenzymes following head injury.

Authors:  D G Thomas; T D Rowan
Journal:  Injury       Date:  1976-05       Impact factor: 2.586

2.  CKBB-isoenzymes as a sign of cerebral injury.

Authors:  L Rabow; G Hedman
Journal:  Acta Neurochir Suppl (Wien)       Date:  1979

3.  Serum-myelin-basic-protein assay in diagnosis and prognosis of patients with head injury.

Authors:  D G Thomas; J W Palfreyman; J G Ratcliffe
Journal:  Lancet       Date:  1978-01-21       Impact factor: 79.321

4.  Enzymatic changes in serum and cerebrospinal fluid in neurological injury.

Authors:  R A Bakay; A A Ward
Journal:  J Neurosurg       Date:  1983-01       Impact factor: 5.115

5.  Cerebrospinal fluid enzymes in acute brain injury. 1. Dynamics of changes in CSF enzyme activity after acute experimental brain injury.

Authors:  A I Maas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-07       Impact factor: 10.154

6.  Brain creatine kinase in blood after acute brain injury.

Authors:  H Somer; M Kaste; H Troupp; A Konttinen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-06       Impact factor: 10.154

7.  Blood creatine kinase isoenzyme BB in boxers.

Authors:  C E Brayne; L Dow; S P Calloway; R J Thompson
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

8.  Creatine kinase isoenzymes in acute brain injury.

Authors:  M Kaste; J Hernesniemi; H Somer; M Hillbom; A Konttinen
Journal:  J Neurosurg       Date:  1981-10       Impact factor: 5.115

9.  The prognosis of patients with concussion and increased creatine kinase BB in the cerebrospinal fluid.

Authors:  H K Nordby; P Urdal; H Bjørnaes
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

10.  The diagnostic value of measuring creatine kinase BB activity in cerebrospinal fluid following acute head injury.

Authors:  H K Nordby; P Urdal
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

View more
  5 in total

1.  Enzymatic changes in the cerebrospinal fluid as indices of pathological change.

Authors:  A Paşaoğlu; H Paşaoğlu
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

2.  Creatin-kinase-BB in blood after severe head injury.

Authors:  A Niedeggen; D Adelt; R Berndt; C Lautz
Journal:  Neurosurg Rev       Date:  1989       Impact factor: 3.042

3.  Creatine-kinase-BB after severe head-injury as an index of prognosis in relation to nature of trauma and patients age.

Authors:  A Niedeggen; D Adelt; R Berndt; T Hopf
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

4.  Persistent metabolic sequelae of severe head injury in humans in vivo.

Authors:  T A Cadoux-Hudson; D Wade; D J Taylor; B Rajagopalan; J G Ledingham; M Briggs; G K Radda
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

5.  Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage.

Authors:  I M Skogseid; H K Nordby; P Urdal; E Paus; F Lilleaas
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.